Cardiovascular monitoring startup Retia Medical raised $7 million in a Series A funding round the company plans to use to develop its minimally-invasive signal processor for high-risk patients.
East Lansing, Mich.-based Retia is working on a system that will monitor cardiac output and other key measures of cardiac health accurately when patients go into shock.